Profit

HDFC Sec's pharma picks

PUBLISHED ON: September 30, 2009 | Duration: 5 min, 39 sec

facebooktwitteremailkoo
loading..
Ranjit Kapadia, VP at HDFC Securities, said that he sees good potential for upsides in Lupin, Wyeth, Dishman and Pfizer.
ALSO WATCH
Explained: How Climate Change Poses A Health Risk To India

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com